August 19: The Gardasil Vaccine

virginia women's center

Gardasil, a vaccine that is approved for females and males ages nine to 26, protects against four strains of the human papillomavirus (HPV). Virginia Women’s Center was the only research site in the Richmond area involved in the clinical trial leading to the approval of the Gardasil vaccine in 2006. In females, Gardasil helps protect against the two types of HPV that cause about 70 percent of cervical cancer cases and two additional types that cause 90 percent of genital warts cases. In males, Gardasil helps protect against 90 percent of genital warts cases.

Gardasil is ideally given to patients before they become sexually active. The vaccine is given in three shots over a period of six months. Routine vaccination is recommended for boys and girls at age 11-12. However, it is also recommended for older teens and young adults who were not vaccinated when younger.

Learn more: http://www.virginiawomenscenter.com/blog/gynecology/encouraging-decline-in-hpv-rates/

SHARE
Rhonda is the mother of two adult daughters and a grandmother to five wonderful grandchildren – and our only grandmother on staff. She spent 25 years in corporate healthcare managing prenatal and disease management programs. She is the Content Manager for Richmondmom and contributes her expertise as both a mom and grandmother – while sorting out the many opportunities for our valuable advertisers.